Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-11 4:34 pm Purchase |
2025-03-31 | 13G | Talphera, Inc. TLPH |
Rosalind Advisors, Inc. | 7,642,515 9.900% |
7,642,515 (New Position) |
Filing History |
| 2025-02-14 3:58 pm Sale |
2024-12-31 | 13G | PolyPid Ltd. PYPD |
Rosalind Advisors, Inc. | 4,081,088 9.900% |
-4,500 (-0.11%) |
Filing History |
| 2025-02-13 1:41 pm Purchase |
2025-02-13 | 13G | Trevi Therapeutics, Inc. TRVI |
Rosalind Advisors, Inc. | 1,062,500 1.200% |
312,500 (+41.67%) |
Filing History |
| 2025-02-13 12:50 pm Unchanged |
2024-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rosalind Advisors, Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-02-12 11:29 am Purchase |
2024-12-31 | 13G | Biofrontera Inc. BFRI |
Rosalind Advisors, Inc. | 9,962,649 9.900% |
2,765,873 (+38.43%) |
Filing History |
| 2025-02-11 4:18 pm Purchase |
2024-12-31 | 13G | MediWound Ltd. MDWD |
Rosalind Advisors, Inc. | 791,315 7.200% |
163,265 (+26.00%) |
Filing History |
| 2025-02-10 4:14 pm Purchase |
2024-12-31 | 13G | PolyPid Ltd. PYPD |
Rosalind Advisors, Inc. | 4,085,588 9.900% |
3,399,416 (+495.42%) |
Filing History |
| 2025-02-10 4:03 pm Purchase |
2024-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Rosalind Advisors, Inc. | 715,231 9.900% |
250,554 (+53.92%) |
Filing History |
| 2025-02-07 11:58 am Purchase |
2024-12-31 | 13G | OptiNose, Inc. OPTN |
Rosalind Advisors, Inc. | 964,587 8.700% |
964,587 (New Position) |
Filing History |
| 2025-02-07 11:24 am Purchase |
2024-12-31 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 9,933,964 9.900% |
2,495,783 (+33.55%) |
Filing History |
| 2025-02-04 3:35 pm Purchase |
2024-12-31 | 13G | Myomo, Inc. MYO |
Rosalind Advisors, Inc. | 7,574,330 9.900% |
2,998,945 (+65.55%) |
Filing History |
| 2025-02-03 4:57 pm Purchase |
2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 7,472,745 9.900% |
502,320 (+7.21%) |
Filing History |
| 2025-01-27 4:02 pm Purchase |
2024-12-23 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors, Inc. | 6,659,993 9.900% |
3,896,525 (+141.00%) |
Filing History |
| 2024-12-02 11:53 am Unchanged |
2024-11-12 | 13D | NeurAxis, Inc. NRXS |
Rosalind Advisors, Inc. | 2,100,840 9.900% |
0 (Unchanged) |
Filing History |
| 2024-12-02 09:57 am Purchase |
2024-11-12 | 13G | NeurAxis, Inc. NRXS |
Rosalind Advisors, Inc. | 2,100,840 9.900% |
2,100,840 (New Position) |
Filing History |
| 2024-11-15 10:33 am Unchanged |
2024-10-30 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors, Inc. | 2,763,468 9.900% |
0 (Unchanged) |
Filing History |
| 2024-11-14 9:46 pm Unchanged |
2024-10-30 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors, Inc. | 2,763,468 9.900% |
0 (Unchanged) |
Filing History |
| 2024-11-06 10:48 am Sale |
2024-10-31 | 13G | Biofrontera Inc. BFRI |
Rosalind Advisors, Inc. | 7,196,776 6.900% |
-675,713 (-8.58%) |
Filing History |
| 2024-10-28 4:02 pm Unchanged |
2024-09-30 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 7,438,181 9.800% |
0 (Unchanged) |
Filing History |
| 2024-10-23 3:14 pm Unchanged |
2024-09-30 | 13G | Biofrontera Inc. BFRI |
Rosalind Advisors, Inc. | 7,872,489 8.900% |
0 (Unchanged) |
Filing History |